News Headlines Article

Rheumatoid arthritis drug prices on the rise
Modern Healthcare

Rheumatoid arthritis drug prices have risen steeply over the past three years, despite little to no change in composition, experts and insurers say.

The wholesale cost of Enbrel, a drug used to treat a number of chronic conditions, has increased 80.3% since 2013, and now exceeds $4,000 for a 30-day supply, according to data gathered by the Alliance of Community Health Plans. The price of Humira went up 68.7% to roughly $3,700 in the same time frame, and the price of Xeljanz rose 44.3% to over $3,100.